Page 2 - Acinetobacter News Today

Gut dysbiosis among critically ill individuals

Researchers use nanopore sequencing to determine the fungal and bacterial microbiota in the lungs of COVID-19 and non-COVID-19 patients.

Microbial diversity in residential kitchens across five European countries was examined, revealing common bacterial genera/families and their distribution on cleaning utensils and kitchen surfaces. The study highlights variations in microbial composition by country, object type, and cleaning utensil material.

MyJournals.org - Science - IJMS, Vol. 24, Pages 9525: Efflux-Related Carbapenem Resistance in Acinetobacter baumannii Is Associated with Two-Component Regulatory Efflux Systems’ Alteration and Insertion of ΔAbaR25-Type Island Fragment (International Journal of Molecular Sciences)

Using an artificial intelligence algorithm, researchers at MIT and McMaster University have identified a new antibiotic that can kill a type of bacteria that is responsible for many drug-resistant infections.

By Sabela Ojea The Food and Drug Administration said Tuesday that it approved Innovivas Xacduro pneumonia treatment, which fights the Acinetobacter bacteria. The federal regulator said... | May 23, 2023

Carbapenem-resistant Acinetobacter baumannii (CRAB) was brought into the ICU, in Hangzhou, on multiple occasions as patients were admitted, creating a large 'reservoir' of the bacteria which contaminated beds and equipment.

MyJournals.org - Science - Clonal relatedness of carbapenem-resistant Acinetobacter baumannii: high prevalence of ST136pas in a burn center (Annals of Clinical Microbiology and Antimicrobials)

The panel on Monday unanimously voted in favor of Innovivas experimental antibiotic in the treatment of serious bacterial infections, typically associated with hospitalizations, the company said.

Researchers highlight the need for prioritizing research on antimicrobial-resistant organism forecasting.